Article

Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients

Topic: Business DevelopmentPublished February 14, 2022
No ratings yet390 viewsSign in to rate
As a chemical supplier and a close partner for many pharmaceutical companies, universities and research institutions, Alfa Chemistry recently announces to offer a variety of synthetic chemical APIs, including: donepezil, dexmedetomidine hydrochloride, lenalidomide, parecoxib sodium, rivaroxaban, tofacitinib citrate, tamoxifen citrate, epalrestat, edaravone. All can be used in pharmaceutical preparation. "As the market for drug discovery and drug manufacturing expands dramatically over the past decade, the demand for active pharmaceutical ingredients (APIs) hence enjoys a big growth. And in response to this trend, our management decides to introduce a new product line, providing a series of high-quality synthetic APIs with the most reasonable price," says the Marketing Chief of Alfa Chemistry. ”Previously, we have already been a trust-worthy Contract Research Organization (CRO) for the pharmaceutical and biotechnology industries, offering pre-formulation drug discovery, formulation and process development, custom synthesis, and scale up services for many years. We believe our relationship with our partners will be further strengthened after the launch of these popular APIs.” As for now, Alfa Chemistry offers the following synthetic chemical APIs: Donepezil Donepezil is a white or almost white crystalline powder. It is a potent, selective, noncompetitive, and rapidly reversible inhibitor of acetylcholinesterase (AChEI) and is licensed for the treatment of Alzheimer disease (AD) and other types of dementia. Dexmedetomidine Hydrochloride Also a white or almost white powder that is freely soluble in water, dexmedetomidine hydrochloride is, unlike other commonly used drugs such as propofol and fentanyl, notable for its ability to provide sedation without risk of respiratory depression and can provide cooperative or semi-rousable sedation. LenalidomidernLenalidomide is a light yellow powder that is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Parecoxib SodiumrnAs a white or almost white crystalline powder, parecoxib sodium is an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. It is approved throughout much of Europe for short term postoperative pain control. The parecoxib sodium provided by Alfa Chemistry is of high quality and can meet the CP & EP standards. RivaroxabanrnRivaroxaban is an odorless, non-hygroscopic, white to yellowish powder, which is only slightly soluble in organic solvents and practically insoluble in water. Since approved for medical use in the United States in 2011, rivaroxaban has been studied and used in the treatment of thrombosis for years. Tofacitinib Citrate Tofacitinib citrate is a novel, oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The tofacitinib citrate offered by Alfa Chemistry is not only of high quality but can also meet the CP standard. Tamoxifen CitraternTamoxifen citrate is an estrogen receptor antagonist and partial agonist which has been shown to induce apoptosis in human malignant glioma cells and to block VEGF production in breast cancer cells. The tamoxifen citrate provided by Alfa Chemistry is of high quality and can meet the CP & EP standards. EpalrestatrnEpalrestat is a carboxylic acid derivative and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus. The epalrestat provided by Alfa Chemistry is of high quality and can meet the CP & EP standards. EdaravonernEdaravone is available as a clear, colorless liquid provided as a sterile injection solution supplied for intravenous (IV) infusion. It is used in the treatment of amyotrophic lateral sclerosis. Please visit the website https://www.alfa-api.com/ to learn more about Alfa Chemistry's offering of synthetic APIs.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026